机译:蛋白酶体抑制剂Mg132增强了骨肉瘤细胞中的顺铂诱导的细胞凋亡,抑制肿瘤生长
Hubei Polytech Univ Huangshi Cent Hosp Dept Orthoped Affiliated Hosp Edong Healthcare Grp;
Hubei Polytech Univ Huangshi Cent Hosp Dept Orthoped Affiliated Hosp Edong Healthcare Grp;
Hubei Polytech Univ Huangshi Cent Hosp Dept Orthoped Affiliated Hosp Edong Healthcare Grp;
Hubei Polytech Univ Huangshi Cent Hosp Dept Orthoped Affiliated Hosp Edong Healthcare Grp;
Hubei Polytech Univ Huangshi Cent Hosp Dept Orthoped Affiliated Hosp Edong Healthcare Grp;
Hubei Polytech Univ Huangshi Cent Hosp Dept Orthoped Affiliated Hosp Edong Healthcare Grp;
Hebei Finance Univ Int Educ Coll Baoding Hebei Peoples R China;
Hubei Polytech Univ Huangshi Cent Hosp Dept Orthoped Affiliated Hosp Edong Healthcare Grp;
MG132; Osteosarcoma (OS); Cisplatin; Synergistic efficacy; Cell viability; Apoptosis;
机译:蛋白酶体抑制剂Mg132增强了骨肉瘤细胞中的顺铂诱导的细胞凋亡,抑制肿瘤生长
机译:蛋白酶体抑制剂MG132增强TRAIL诱导的细胞凋亡并抑制人骨肉瘤OS732细胞的侵袭
机译:p38 |α|的抑制MAPK通过在体外调节Hsp27,Bcl-XL,Mcl-1和p53水平来增强蛋白酶体抑制剂诱导的骨髓瘤细胞凋亡,并在体内抑制肿瘤生长
机译:总Pa药苷抑制K562细胞和S180荷瘤小鼠的肿瘤生长并诱导其凋亡。
机译:小分子抑制剂VMY-1-103在癌细胞系中诱导凋亡和自噬,并降低体内肿瘤的生长。
机译:蛋白酶体抑制剂MG132抑制增殖并促进顺铂诱导的人食管鳞状细胞癌细胞凋亡
机译:通过在体外调节Hsp27,Bcl-XL,MCL-1和P53水平,通过调节Hsp27,Bcl-XL,MCL-1和P53水平来抑制P38αMAPK增强蛋白酶体抑制剂诱导的骨髓瘤细胞凋亡并抑制体内肿瘤生长